SMAD4 Expression and Its Association With Treatment Resistance and Clinical Outcomes in Oral Squamous Cell Carcinoma Treated With Preoperative Chemoradiotherapy
Cancer Reports · 2026
DOI: 10.1002/cnr2.70654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2026. Verfasst von Junki Sakata und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Smad4 Protein, Mouth Neoplasms, Drug Resistance, Neoplasm, Carcinoma, Squamous Cell. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Background
Small mothers against decapentaplegic homologue 4 (SMAD4) plays an important role in transforming growth factor (TGF)‐β signaling and is associated with various cancers. However, little is known about SMAD4 expression in oral squamous cell carcinoma (OSCC).
Aim
To investigate the clinical and biological significance of SMAD4 expression in OSCC. Methods and Results Immunohistochemical analysis was performed to detect SMAD4 expression in 90 OSCC specimens obtained from patients who underwent preoperative chemoradiotherapy and surgery (phase II study). We also investigated the correlation between SMAD4 expression and various clinicopathological features. In vitro experiments were performed to assess the effects of SMAD4 expression on chemosensitivity and changes in apoptosis‐related molecules. Notably, low SMAD4 expression was significantly correlated with an increased risk of lymph node metastasis, poor response to chemoradiotherapy, and adverse prognosis in patients with OSCC who underwent preoperative 5‐FU‐based chemoradiotherapy. Additionally, SMAD4 downregulation in OSCC cells decreased sensitivity to cisplatin and 5‐fluorouracil and was associated with an increase in cIAP2 expression.
Conclusion
The reduced expression of SMAD4 has been linked to both chemotherapy resistance and prognosis in OSCC. However, it may not function as an independent prognostic biomarker. Further research is necessary to determine whether these findings can be generalized to the broader OSCC population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Oral and Maxillofacial Surgery, Jichi Medical University, Tochigi, Japan.
- Division of Oral and Maxillofacial Surgery, Tsuruta Hospital, Kumamoto, Japan.
- Section of Oral Oncology, Fukuoka Dental College, Fukuoka, Japan.
- Division of Oral and Maxillofacial Surgery, Ariake Medical Center, Arao, Japan.
- Department of Radiological Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
ORCID-Profile: Junki Sakata, Akiyuki Hirosue, Ryoji Yoshida, Hikaru Nakashima, Tatsuro Yamamoto, Kenta Kawahara, Ryo Toya, Takaaki Ito, Hideki Nakayama
Förderung
- JSPS KAKENHI
Zitieren
APA
Sakata, J., Hirosue, A., Yoshida, R., Matsuoka, Y., Todoroki, Y., Arita, H., Nakashima, H., Yamamoto, T., Takahashi, N., Hirayama, M., Kawahara, K., Toya, R., Murakami, R., Ito, T., Kuwahara, Y., & Nakayama, H. (2026). SMAD4 Expression and Its Association With Treatment Resistance and Clinical Outcomes in Oral Squamous Cell Carcinoma Treated With Preoperative Chemoradiotherapy. Cancer Reports. https://doi.org/10.1002/cnr2.70654
Vancouver
Sakata J, Hirosue A, Yoshida R, Matsuoka Y, Todoroki Y, Arita H, et al. SMAD4 Expression and Its Association With Treatment Resistance and Clinical Outcomes in Oral Squamous Cell Carcinoma Treated With Preoperative Chemoradiotherapy. Cancer Reports. 2026. doi:10.1002/cnr2.70654
BibTeX
@article{Sakata2026,
author = {Sakata, Junki and Hirosue, Akiyuki and Yoshida, Ryoji and Matsuoka, Yuichiro and Todoroki, Yusei and Arita, Hidetaka and Nakashima, Hikaru and Yamamoto, Tatsuro and Takahashi, Nozomu and Hirayama, Masatoshi and Kawahara, Kenta and Toya, Ryo and Murakami, Ryuji and Ito, Takaaki and Kuwahara, Yoshikazu and Nakayama, Hideki},
title = {SMAD4 Expression and Its Association With Treatment Resistance and Clinical Outcomes in Oral Squamous Cell Carcinoma Treated With Preoperative Chemoradiotherapy},
journal = {Cancer Reports},
year = {2026},
doi = {10.1002/cnr2.70654}
}
EUVIMED